APDN - アプライドDNAサイエンシス (Applied DNA Sciences Inc) アプライドDNAサイエンシス

 APDNのチャート


 APDNの企業情報

symbol APDN
会社名 Applied DNA Sciences Inc (アプライドDNAサイエンシス)
分野(sector) Consumer Services   消費者サービス
産業(industry) Other Consumer Services  
業種 化学_特殊化学製品   工業(Industrials)
概要 事業概要 Applied DNA Sciences Inc. is engaged in creating security solutions addressing the challenges of modern commerce. The Company is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). Its principal technology platform includes SigNature DNA SigNature T DNA fiberTyping DNAnet digitalDNA SigNify and Beacon. Its SigNify IF portable DNA reader provides definitive real-time authentication of SigNature DNA in the field-DNA becomes a solution for supply chain integrity. SigNature DNA is the Company''s platform ingredient at the core of all its security solutions. It provides forensic power and protection for a range of applications. SigNature T DNA is a tagging and authentication system specifically designed for textiles and apparel. DNAnet is a DNA marker that can be used to definitively link evidence and offenders to specific crime scenes and help return stolen or lost property to its rightful owner.   アプライドDNAサイエンシスは、米国のDNAセキュリティ―ソリュ―ション会社。製品、ブランド、知的財産権の偽造や転用を防ぐため、北米と欧州で、DNAタグを利用した偽造防止技術を供給する。主な製品は、「SigNatureDNA」、「fiberTyping」、「 DNANet」、 「digitalDNA」など。本社は、ニューヨーク州スト―ニ―ブルック。   Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion. Its products include the following brands: Applied DNA Sciences, SigNature, molecular tags, SigNature, T molecular tags, fiberTyping, DNAnet, digitalDNA, SigNify, BackTrac, Beacon, and CertainT. The company was founded in 1983 and is headquartered in Stony Brook, NY.
本社所在地 50 Health Sciences Drive Stony Brook NY 11790 USA
代表者氏名 James A. Hayward ジェームズ・A・ヘイワード
代表者役職名 Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者(CEO)
電話番号 +1 631-240-8800
設立年月日 1983年
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 60人
url www.adnas.com
nasdaq_url https://www.nasdaq.com/symbol/apdn
adr_tso
EBITDA EBITDA(百万ドル) -10.19729
終値(lastsale) 1.42
時価総額(marketcap) 42759120.94
時価総額 時価総額(百万ドル) 43.36136
売上高 売上高(百万ドル) 3.85349
企業価値(EV) 企業価値(EV)(百万ドル) 40.84654
当期純利益 当期純利益(百万ドル) -11.07232
決算概要 決算概要 BRIEF: For the nine months ended 30 June 2018 Applied DNA Sciences Inc revenues decreased 25% to $2.7M. Net loss decreased 18% to $8.2M. Revenues reflect United States (Country) segment decrease of 58% to $1.1M Europe segment decrease of 17% to $799K. Lower net loss reflects Selling general and administrative decrease of 29% to $7.5M (expense) Depreciation and amortization decrease of 13% to $426K (expense).

 APDNのテクニカル分析


 APDNのニュース

   Applied DNA Sciences : Subsidiary, LineaRx, Inc., Sign Licensing Agreement with LifeSensors, Inc. | MarketScreener  2020/01/13 14:53:11 MarketScreener
STONY BROOK N.Y., January 13, 2020 - Applied DNA Sciences Inc. announced today that LineaRx, Inc. , its majority-owned subsidiary focused on next-generation biotherapeutics and… | January 13, 2020
   Applied DNA Subsidiary, LineaRx, Inc., Signs Licensing Agreement with LifeSensors, Inc.  2020/01/13 14:15:00 Business Wire
STONY BROOK N.Y.--(BUSINESS WIRE)---- $apdn #genetherapy--Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) announced today that LineaRx, Inc. (“LineaRx”), its majority-owned subsidiary focused on next-generation biotherapeutics and cancer diagnostics, has signed a licensing agreement with LifeSensors, Inc. (“LifeSensors”), to incorporate LifeSensors’ high expression SUMO-fusion technologies into the Company’s linear DNA amplicons designed and produced for therapeutic applications (the “Agreem
   Colorcon, Inc. Launches On-Dose Authentication Platform From Applied DNA Sciences  2019/12/23 14:30:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)--Colorcon, Inc. Launches On-Dose Authentication Platform From Applied DNA Sciences
   Applied DNA and Old Port Oil to Conduct First Pilot to Tag CBD Oil  2019/12/11 14:15:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $apdn #authenticity--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity, traceability solutions and nucleic acid-based biotherapeutic development, announced today it will conduct a funded pre-commercial pilot to tag cannabidiol (CBD) oil for Old Port Oil, Company (“Old Port Oil”) using its CertainT® platform to tag, test and track the CBD oil product. Newly formed Old Port Oil, a
   Applied DNA Sciences and Reliance Industries Sign MOU to Incorporate CertainT Forensic Traceability Into R|Elan Fabric and Recron GreenGold® Recycled Polyester Fiber and Filament  2019/12/10 14:20:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $apdn #anticounterfeiting--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”), a leader in large-scale PCR-based DNA manufacturing and authentication, announced today that it has signed a non-binding memorandum of understanding (the “MOU”) with Reliance Industries Ltd. (“RIL”) to develop and commercialize apparel made from RIL’s R|Elan GreenGold® fabric and Recron GreenGold® recycled polyester fiber and filament powered by CertainT. The collaboration as set forth in the MOU, pro
   Colorcon, Inc. Launches On-Dose Authentication Platform From Applied DNA Sciences  2019/12/23 14:30:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)--Colorcon, Inc. Launches On-Dose Authentication Platform From Applied DNA Sciences
   Applied DNA and Old Port Oil to Conduct First Pilot to Tag CBD Oil  2019/12/11 14:15:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $apdn #authenticity--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity, traceability solutions and nucleic acid-based biotherapeutic development, announced today it will conduct a funded pre-commercial pilot to tag cannabidiol (CBD) oil for Old Port Oil, Company (“Old Port Oil”) using its CertainT® platform to tag, test and track the CBD oil product. Newly formed Old Port Oil, a
   Applied DNA Sciences and Reliance Industries Sign MOU to Incorporate CertainT Forensic Traceability Into R|Elan Fabric and Recron GreenGold® Recycled Polyester Fiber and Filament  2019/12/10 14:20:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $apdn #anticounterfeiting--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”), a leader in large-scale PCR-based DNA manufacturing and authentication, announced today that it has signed a non-binding memorandum of understanding (the “MOU”) with Reliance Industries Ltd. (“RIL”) to develop and commercialize apparel made from RIL’s R|Elan GreenGold® fabric and Recron GreenGold® recycled polyester fiber and filament powered by CertainT. The collaboration as set forth in the MOU, pro
   Applied DNA Schedules Fiscal 2019 Fourth Quarter Financial Results Conference Call for Thursday, December 12, 2019 at 4:30 PM ET  2019/12/05 10:00:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN), announced today it plans to release financial results for its fiscal 2019 fourth quarter ended September 30, 2019 after market close on Thursday, December 12, 2019. In conjunction with the release, the Company has scheduled a conference call at 4:30 p.m. Eastern Time that will also be broadcast live over the Internet. What: Applied DNA’s Fiscal 2019 Fourth Quarter Financial Results Conference Call When: Thursday, Dec
   Applied DNA Sciences Subsidiary LineaRx Signs Agreement with TYME Technologies for Functional Invasive Circulating Tumor Cell Assay Services in Pancreatic Cancer Trial  2019/11/26 17:30:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN; the “Company” or “Applied DNA”) announced today that LineaRx, Inc., the Company’s majority-owned subsidiary focused on next-generation biotherapeutics and diagnostics, has signed a definitive agreement with Tyme Technologies, Inc. to supply the Company’s Vita-AssayTM invasive Circulating Tumor Cell (iCTC) capture assay and associated services for use in the pivotal stage of the TYME-88-PANC clinical trial for patients
   Applied DNA and Old Port Oil to Conduct First Pilot to Tag CBD Oil  2019/12/11 14:15:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $apdn #authenticity--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity, traceability solutions and nucleic acid-based biotherapeutic development, announced today it will conduct a funded pre-commercial pilot to tag cannabidiol (CBD) oil for Old Port Oil, Company (“Old Port Oil”) using its CertainT® platform to tag, test and track the CBD oil product. Newly formed Old Port Oil, a
   Applied DNA Sciences and Reliance Industries Sign MOU to Incorporate CertainT Forensic Traceability Into R|Elan Fabric and Recron GreenGold® Recycled Polyester Fiber and Filament  2019/12/10 14:20:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $apdn #anticounterfeiting--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”), a leader in large-scale PCR-based DNA manufacturing and authentication, announced today that it has signed a non-binding memorandum of understanding (the “MOU”) with Reliance Industries Ltd. (“RIL”) to develop and commercialize apparel made from RIL’s R|Elan GreenGold® fabric and Recron GreenGold® recycled polyester fiber and filament powered by CertainT. The collaboration as set forth in the MOU, pro
   Applied DNA Schedules Fiscal 2019 Fourth Quarter Financial Results Conference Call for Thursday, December 12, 2019 at 4:30 PM ET  2019/12/05 10:00:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN), announced today it plans to release financial results for its fiscal 2019 fourth quarter ended September 30, 2019 after market close on Thursday, December 12, 2019. In conjunction with the release, the Company has scheduled a conference call at 4:30 p.m. Eastern Time that will also be broadcast live over the Internet. What: Applied DNA’s Fiscal 2019 Fourth Quarter Financial Results Conference Call When: Thursday, Dec
   Applied DNA Sciences Subsidiary LineaRx Signs Agreement with TYME Technologies for Functional Invasive Circulating Tumor Cell Assay Services in Pancreatic Cancer Trial  2019/11/26 17:30:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN; the “Company” or “Applied DNA”) announced today that LineaRx, Inc., the Company’s majority-owned subsidiary focused on next-generation biotherapeutics and diagnostics, has signed a definitive agreement with Tyme Technologies, Inc. to supply the Company’s Vita-AssayTM invasive Circulating Tumor Cell (iCTC) capture assay and associated services for use in the pivotal stage of the TYME-88-PANC clinical trial for patients
   Applied DNA Sciences Regains Compliance with Nasdaq Listing Standards  2019/11/25 18:17:00 Business Wire
STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”) or (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity, traceability solutions and nucleic acid-based biotherapeutic research, today announced that it has received notification from Nasdaq that the Company has regained compliance with Nasdaq’s minimum bid price and stockholders’ equity rules and met the requirements of the Nasdaq Hearing Panel d

 関連キーワード  (化学_特殊化学製品 米国株 アプライドDNAサイエンシス APDN Applied DNA Sciences Inc)

化学産業により作られた製品は、経済の基盤を成し自動車や電機産業のほか、日用雑貨や医薬品など生活の隅々で使用されている。化学産業は経済活動の影響を受ける面が大きく、関連株も景気動向に左右される。化学産業の基礎資材は石油から作られ原油価格の影響も受けやすい。また、日本の化学産業はアジアなど海外企業との競争も激しくなっている。

 twitter  (公式ツイッターやCEOツイッターなど)